title: Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment.
abstract: This review deals with the role of microorganisms in spontaneous regression of a tumour. Spontaneous cancer regression is a phenomenon that has been described for many centuries. One of the most well known methods of inducing spontaneous regression of cancer is the application of Coley's toxin (heat-killed Streptococcus pyogenes and Serratia marcescens), which has been used for the successful treatment of sarcomas, carcinomas, lymphomas, myelomas and melanomas. In clinical practice, the use of Bacillus Calmette-Guérin vaccine for the treatment of superficial urinary bladder cancer is the most common instance of the application of microorganisms for the treatment of cancer. This review provides further information on other tested bacteria--Clostridium spp., Bifidobacterium spp., Lactobacillus spp. and Salmonella spp.--in this field of study. Among new age methods, bactofection, alternative gene therapy, combination bacteriolytic therapy and bacteria-directed enzyme prodrug therapy are some of the potential cancer treatment modalities that use microorganisms. We have also provided information about the interconnection among microorganisms, immune system response, and the possible mechanisms involved in the spontaneous regression of tumours.
authors.affiliation: aInstitute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov bDepartment of Surgery, First Medical Faculty, Charles University and Hospital Na Bulovce, Prague, Czech Republic.
authors.forename: Petra
authors.initials: P
authors.lastname: Kucerova
authors.forename: Monika
authors.initials: M
authors.lastname: Cervinkova
mesh_terms: D001500:BCG Vaccine / Q000627:therapeutic use; D018407:Bacterial Physiological Phenomena; D001427:Bacterial Toxins / Q000266:history / Q000627:therapeutic use; D001644:Bifidobacterium / Q000235:genetics / Q000378:metabolism; D003013:Clostridium / Q000235:genetics / Q000378:metabolism; D003131:Combined Modality Therapy; D015316:Genetic Therapy; D049670:History, 17th Century; D049671:History, 18th Century; D049672:History, 19th Century; D049690:History, Ancient; D006801:Humans; D007778:Lactobacillus / Q000235:genetics / Q000378:metabolism; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000276:immunology / Q000382:microbiology* / Q000628:therapy*; D012475:Salmonella / Q000235:genetics / Q000378:metabolism
chemical_list: D001500:BCG Vaccine; D001427:Bacterial Toxins
references.citation: Cancer Lett. 2008 Jan 18;259(1):16-27
references.pmid: 18063294
references.citation: Anticancer Res. 2009 Jun;29(6):1873-8
references.pmid: 19528442
references.citation: Cell Cycle. 2010 Nov 15;9(22):4518-24
references.pmid: 21135579
references.citation: Oncotarget. 2015 May 10;6(13):11369-77
references.pmid: 25957417
references.citation: Int J Med Microbiol. 2009 Mar;299(3):161-76
references.pmid: 18948059
references.citation: Cancer Detect Prev. 2006;30(1):83-93
references.pmid: 16490323
references.citation: Oncotarget. 2015 Feb 20;6(5):2615-22
references.pmid: 25575815
references.citation: Trends Mol Med. 2012 Jul;18(7):417-25
references.pmid: 22721939
references.citation: Cell Prolif. 2010 Feb;43(1):41-8
references.pmid: 19922490
references.citation: Acta Biochim Pol. 2013;60(3):285-97
references.pmid: 23828775
references.citation: Pathol Res Pract. 2010 Jan 15;206(1):1-8
references.pmid: 19945228
references.citation: Cancer Control. 2002 Jan-Feb;9(1):22-30
references.pmid: 11907463
references.citation: Cancer Res. 2006 Aug 1;66(15):7647-52
references.pmid: 16885365
references.citation: Cell Cycle. 2009 Mar 15;8(6):870-5
references.pmid: 19221501
references.citation: Int J Mol Sci. 2014;15(8):14546-54
references.pmid: 25196596
references.citation: PLoS One. 2015;10(8):e0134324
references.pmid: 26237416
references.citation: Cancer Sci. 2010 Mar;101(3):751-8
references.pmid: 20015287
references.citation: J Cell Biochem. 2014 Nov;115(11):1996-2003
references.pmid: 24924355
references.citation: J Biomed Sci. 2010;17(1):21
references.pmid: 20331869
references.citation: Semin Immunol. 2010 Jun;22(3):183-9
references.pmid: 20299242
references.citation: PLoS One. 2009;4(8):e6692
references.pmid: 19693266
references.citation: Postgrad Med J. 2003 Dec;79(938):672-80
references.pmid: 14707241
references.citation: J Control Release. 2013 Aug 28;170(1):120-31
references.pmid: 23688772
references.citation: J S Afr Vet Assoc. 2009 Jun;80(2):92-6
references.pmid: 19831270
references.citation: J Bacteriol. 2003 May;185(9):2683-6
references.pmid: 12700245
references.citation: J Surg Res. 2010 Dec;164(2):248-55
references.pmid: 19766244
references.citation: Cancer Immunol Res. 2013 Aug;1(2):123-33
references.pmid: 24455752
references.citation: Med Hypotheses. 2002 Feb;58(2):115-9
references.pmid: 11812185
references.citation: Cancer Cell Int. 2005 Jul 11;5:21
references.pmid: 16004618
references.citation: Anticancer Res. 2012 Oct;32(10):4331-7
references.pmid: 23060555
references.citation: Clin Cancer Res. 2013 Jun 1;19(11):2834-41
references.pmid: 23536438
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14748-50
references.pmid: 11752416
references.citation: PLoS One. 2010;5(5):e10498
references.pmid: 20463924
references.citation: Cancer Sci. 2010 Sep;101(9):1925-32
references.pmid: 20579076
references.citation: J Cell Biochem. 2014 Jul;115(7):1254-61
references.pmid: 24435915
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):755-60
references.pmid: 15644448
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14098-103
references.pmid: 12393814
references.citation: Int J Nanomedicine. 2011;6:3011-9
references.pmid: 22162658
references.citation: Cancer Immunol Immunother. 2001 Oct;50(8):391-6
references.pmid: 11726133
references.citation: Anticancer Res. 2012 Jul;32(7):2501-8
references.pmid: 22753706
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10170-4
references.pmid: 17548809
references.citation: J Cell Biochem. 2009 Apr 15;106(6):992-8
references.pmid: 19199339
references.citation: Indian J Cancer. 2011 Apr-Jun;48(2):246-51
references.pmid: 21768675
references.citation: Oncotarget. 2014 Dec 30;5(24):12849-61
references.pmid: 25528763
references.citation: J Transl Med. 2006 Mar 28;4:14
references.pmid: 16566840
references.citation: Oncotarget. 2014 Dec 15;5(23):12346-57
references.pmid: 25402324
references.citation: Cell Cycle. 2013 Sep 1;12(17):2774-80
references.pmid: 23966167
references.citation: J Natl Cancer Inst. 2008 Oct 1;100(19):1389-400
references.pmid: 18812551
references.citation: J Nat Sci Biol Med. 2011 Jan;2(1):43-9
references.pmid: 22470233
references.citation: J Immunol. 2013 Jan 1;190(1):469-78
references.pmid: 23225891
references.citation: Cell Cycle. 2012 Feb 1;11(3):628-32
references.pmid: 22274398
references.citation: PLoS One. 2015;10(2):e0117417
references.pmid: 25689852